Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Sarcoma
Interventions
DRUG

valganciclovir

Trial Locations (3)

10021

Memorial Sloan - Kettering Cancer Center, New York

New York Weill Cornell Cancer Center at Cornell University, New York

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

New York Presbyterian Hospital

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

collaborator

University of North Carolina, Chapel Hill

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00096538 - Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter